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Background: Acute lower respiratory illness (ALRI) is a major global cause of morbidity and mortality among
children under 5. Antibiotic treatment for ALRI is inexpensive and decreases case fatality, but care-seeking patterns
and appropriate treatment vary widely across countries. This study sought to examine patterns of appropriate
treatment and estimate the burden of cases of untreated ALRI in high mortality countries.
Methods: This study used cross-sectional survey data from the Phase 5/Phase 6 DHS and MIC3/MICS4 for 39
countries. We analyzed care-seeking patterns and antibiotic treatment based on country-level trends, and estimated
the burden of untreated cases using country-level predictors in a general linear model.
Results: According to this analysis, over 66 million children were not treated with antibiotics for ALRI in 2010.
Overall, African countries had a lower proportion of mothers who sought care for a recent episode of ALRI (41% to
86%) relative to Asian countries (75% to 87%). Seeking any care for ALRI was inversely related to seeking public
sector care. Treatment with antibiotics ranged from 8% in Nepal to 87% in Jordan, and was significantly associated
with urban residence.
Conclusions: Untreated ALRI remains a substantial problem in high mortality countries. In Asia, the large
population numbers lead to a high burden of children with untreated ALRI. In Africa, care-seeking behaviors and
access to care issues may lead to missed opportunities to treat children with antibiotics.
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According to the 2010 Global Burden of Disease esti-
mates, acute lower respiratory infection (ALRI) is the
leading cause of death among children aged under five
years in developing countries [1]. Although viruses are
the more common etiologic agent of ALRI in children
[2], bacterial pathogens are associated with higher risk of
morbidity and mortality [3] and viral ALRIs are often
followed by bacterial infections [4]. While two of the* Correspondence: emosites@uw.edu
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unless otherwise stated.most common etiologies of bacterial ALRI, Haemophilus
influenza type b (Hib) and Streptococcus pneumoniae,
can be partially prevented through vaccination, vaccine
coverage is not yet widespread in resource-limited set-
tings [5]. Vaccines are not available for any of the other
bacterial pathogens that cause ALRI. Until effective vac-
cines become broadly available and vaccination coverage is
high, proper clinical management remains the most impor-
tant method of preventing childhood mortality from ALRI.
Appropriate clinical management of ALRI consists of
several elements: a caregiver recognizing the signs and
symptoms of severe infection, the child being brought to
a healthcare facility, the healthcare worker making al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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apy. Each of these components provides one or more
pathways by which a child with ALRI might not receive
appropriate treatment.
As a clinical syndrome, ALRI is characterized by fever,
cough, difficult breathing, and rapid breathing although
each of these may be variable in young children and diffi-
cult for caregivers to evaluate. In one analysis, only 20% of
caregivers were able to identify difficulty breathing and
fast breathing as characteristic symptoms [6].
Severity of ALRI upon presentation predicts response
to treatment [7], and therefore prompt care-seeking by
the parents of ill children is critical. However, delays in
care-seeking often occur and can be related to cost, non-
recognition of the severity of illness, differences in the per-
ception of the cause of disease, or geographic barriers
[8-11]. Additionally, poor healthcare infrastructure and/
or lack of appropriate care and medicine contribute to
delays [12].
Correct diagnosis of ALRI is often difficult in areas that
are endemic for diseases with similar clinical presentations,
such as tuberculosis or malaria [13]. Additionally, severity
must be accurately assessed and antibiotic treatment and
oxygen therapy provided, if necessary. The World Health
Organization (WHO) currently recommends intramuscular
ampicillin and gentamycin for inpatients with very severe
pneumonia, and oral amoxicillin or co-trimoxazole for less
severe pneumonia and outpatients [14]. Other common an-
tibiotics for severe ALRI include oral cephalosporins and
macrolides [15]. When needed, antibiotic therapy has dra-
matic effects on child survival; case-fatality rates for treated
ALRI are under 1% while untreated ALRI case-fatality rates
may reach over 10% [16]. However, there are a number of
barriers to receiving appropriate antibiotics at the clinic
level, including stock-outs, understaffing, prescribing pat-
terns of health workers, and diagnostic overlaps with other
infections [11,12,17,18].
Given these challenges, both parental care-seeking and
treatment patterns within facilities vary widely across coun-
tries. The WHO has estimated that globally, only 30% of
children with ALRI are appropriately treated with anti-
biotics [19], though this proportion is likely to be even
lower in high-mortality countries.
To effectively reduce the burden of ALRI mortality, it
is important to understand patterns of care-seeking, as
well as to quantify the number of cases of untreated ALRI
within high mortality countries. However, direct com-
parisons among countries with high mortality are made
difficult by a lack of routinely collected estimates that
use similar methodology. Two exceptions to this are the
Demographic and Health Surveys (DHS) and Multiple
Indicator Cluster Surveys (MICS). These household-level
surveys measure health and demographic indicators ap-
proximately every 5 years in developing countries usingnationally representative samples. They are particularly use-
ful for aggregate estimation of burden because they use a
common, standardized approach. DHS data provides in-
formation on fertility and health topics, while the MICS
is focused on the state of women and children to inform
policy and program decisions. DHS and MICS surveys
have been intentionally developed to be comparable to
each other.
To date, no study has aggregated DHS and MICS indica-
tors to compare ALRI care-seeking and treatment out-
comes globally. Though DHS and MICS data are the best
source of comparable data, many high-mortality countries
have not conducted a DHS or MICS. Fortunately it is pos-
sible to use the information from countries which have
been surveyed to provide information on those which have
not yet been surveyed. This study uses the most recent
DHS and MICS data to address two objectives: 1) gain an
improved understanding of patterns of care-seeking and
antibiotic treatment among countries with DHS and MICS
data, and 2) determine whether country-level factors can
be used to estimate the burden of cases of untreated ALRI
in all high-mortality countries.
Methods
Datasets
DHS datasets (phases 5 and 6) from African and Asian
countries were accessed from http://www.measuredhs.com/
Data/. Datasets were included in the analysis if they con-
tained data points for the components of a restricted ALRI
case definition, and the components of either care-seeking
behavior or antibiotic treatment (see below). MICS data-
sets (MICS3 and MICS4) for Asian and African countries
were accessed from http://www.childinfo.org/mics3_sur
veys.html. MICS antibiotic treatment data were accessed
through the country final reports [20]. MICS country re-
port information was included if it contained the sufficient
data on antibiotic treatment (total and stratified by urban/
rural). Estimates of the number of respiratory infection
cases in each country were calculated using under-5 popu-
lation and pneumonia prevalence data from the Child
Health Epidemiology Research Group (CHERG), which
were recently updated to account for vaccine roll-out [21].
Country-level predictors of the proportion treated with
antibiotics were collated from WHO and World Bank
datasets [5,22].
Data management and analysis were conducted using
Stata SE 11 (Stata Corp, LP). All data were publically avail-
able and not identifiable; therefore ethical review was not
required.
Definitions
DHS and MICS datasets are designed to be highly com-
parable, and questions on the topic of ALRI were asked
in the same manner in both surveys. In this analysis, for
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who was ill in the previous two weeks with a cough ac-
companied by short, rapid breathing which the mother
considered to be chest-related”. Care-seeking was defined
as “mother sought advice or treatment for this illness
from any source”. The variables for seeking medical care
or seeking public sector care were defined as a composite
of answers to the question “the place at which medical
treatment or advice was sought for the last episode of
fever and/or cough”, the answers to which were not mutu-
ally exclusive categories. Seeking medical care specifically
involved seeking care at an appropriate medical provider,
either in the private or public sector, not including phar-
macies. Antibiotic treatment was defined as an affirmative
answer to the question “at any time during the illness, the
child took an antibiotic pills/syrup or injection for this ill-
ness”, or an antibiotic was listed in the “other” or country-
specific field of the question “what drugs did name take?”
Urban or rural residence in the DHS was defined by each
country’s census data [23].
Country-level descriptive analyses
In order to describe the ALRI treatment patterns across
the countries with available data, we calculated the pro-
portions of care-seeking and antibiotic treatment within
each country. These estimates were weighted using the
standard sampling weights which are provided in the DHS
and MICS data. The sampling weights account for each
survey design, which included over- and under-sampling
of particular regions and allow the calculation of overall
national estimates.
We calculated four quantities for each country: (a) the
proportion of children with ALRI who received any care
(# for whom care was sought/total # of ALRI cases); (b)
proportion of children with ALRI who received any medical
care (# children for whom medical care was sought/total #
of ALRI cases); (c) proportion of children with ALRI who
received medical care from a public facility (# of children
for whom public care was sought/# for whom care was
sought); and (d) proportion of children with ALRI who re-
ceived antibiotic treatment (# of children who received anti-
biotics/total # of ALRI cases).
The proportion of children receiving any care was plot-
ted against the proportion of children receiving public sec-
tor care. This trend was evaluated for significance using
robust standard errors to account for heteroscedasticity.
Prediction model for number of untreated ALRI cases
We developed a prediction model to estimate the pro-
portion of children who were not treated for ALRI in 80
high-mortality countries for which DHS or MICS data
were not available. To create this model, we generated a
dataset of 28 countries that did have available data on the
country-level proportion of antibiotic treatment in childrenwith ALRI from the DHS or MICS (year of data collection
ranging from 2006 to 2011). We then evaluated the fol-
lowing independent variables for their association with
antibiotic treatment proportion: proportion of women
receiving at least one antenatal care visit; coverage of
the third dose of the diphtheria, pertussis, and tetanus
vaccine in one-year olds; coverage of Bacillus Calmette-
Guérin (BCG) vaccine in one-year-olds; coverage of
measles-containing virus (MCV) vaccine in one-year-olds;
gross national income (GNI) per capita; health expendi-
tures per capita (PPP); number of nurses/midwives per
1,000 people; percentage of the population living in urban
areas; coverage of oral rehydration salts for the treatment
of diarrhea; infant mortality per 1,000 live births per year;
under-five mortality per 1,000 live births per year; age-
adjusted total mortality per 1,000 people per year; and an
indicator of African or Asian continent. To test these
associations, we conducted univariate analyses using
pairwise linear correlation coefficients. Independent vari-
ables with a correlation coefficient above 0.3 were in-
cluded as potential predictors in a multivariate general
linear model.
The final model was chosen through a backwards step-
wise selection process based on Akaike information criter-
ion (AIC) values. The model included analytic weights
based on the standard errors of the DHS and MICS survey
estimates of the dependent variable, to account for point
estimate variability in the original surveys. The selected
model was then subjected to leave-one-out cross-validation
to estimate overall mean squared error. This model was
used to predict proportions of ALRI that went untreated
for all countries with predictor data. Predictions were lim-
ited to countries with child and overall mortality rates that
lay within the bounds of the countries with DHS or MICS
data, to avoid extrapolation. Finally, the predicted propor-
tions were applied to CHERG estimates of the number of
ALRI cases in each country to obtain an overall estimate of
the absolute number of children who are not treated for re-
spiratory illness each year.
Results
As of August 2012, 17 countries within Africa and Asia
had DHS datasets with information about care-seeking
patterns for ALRI among children under 5 years of age.
Eighteen datasets containing care-seeking information
were available from the MICS datasets. For the predictive
model, eleven countries had DHS datasets with informa-
tion about antibiotic treatment of ALRI (two of which did
not have care-seeking data), while 15 additional countries
had antibiotic treatment information in MICS reports.
Care-seeking patterns
Access to care for children with ALRI was highly vari-
able across countries with recent DHS or MICS datasets
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African countries had a lower percentage of mothers who
sought care for a recent episode of ALRI (41% to 86%, me-
dian 64%) relative to Asian countries (75% to 87%, median
81%). Seeking medical care, specifically, was more com-
mon in African than Asian countries. Those countries
with the highest percentage seeking non-medical care (i.e.,
seeking care from pharmacies, shops, and traditional
healers) were Bangladesh, Nepal, and Swaziland. Overall,
10% to 86% sought care in the public sector for a child’sTable 1 Proportions of ALRI cases seeking care, per Phase 5/6
Dataset Country (year) Any
DHS


















Central African Republic (2010) 41
Mauritania (2011) 46
Lao People’s Republic (2011–12) 50
Cameroon (2006) 54
Togo (2010) 58











*Among all ALRI cases.
**Among those who sought any care.ALRI, and this was more common in African than Asian
countries. In many of the African countries with data
available, over 50% of care was sought in public healthcare
facilities. There was a significant negative correlation be-
tween seeking public sector care and seeking any care at
all (robust p = 0 · 01); in those countries with a low fre-
quency of care-seeking overall, a higher percentage of in-
dividuals sought care in the public sector (Figure 1).
Those countries with higher care-seeking had wider vari-
ability in accessing public sector care.DHS and MICS 3/4
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Figure 1 Proportions of children who received any care compared to those who received public sector care, Phase 5/6 DHS and
MICS 3/4.
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In the 26 countries with DHS or MICS estimates available,
treatment with antibiotics for children with a recent epi-
sode of ALRI ranged from 8% in Nepal to 87% in Jordan
(Table 2). Urban residents had an average of 10 percentage
points higher levels of antibiotic treatment compared to
rural residents (paired p-value for difference < 0 · 001).
Prediction model
The prediction model for untreated ALRI is included in
Table 3. In the selected model, the percent of the coun-
try that was urban and the under-five mortality rate were
the only country-level characteristics that were retained.
The model predicted the proportion of children with ALRI
who were untreated for 108 countries. Across these 108
countries, the estimated number of children with ALRI
who do not receive antibiotics exceeds 66 million per year,
which represents 53% of ALRI cases (see Additional file 1
for list of country-specific data).
Discussion
Antibiotic treatment is an inexpensive, effective way to
increase child survival for children with ALRI in resource-
limited settings. In this study, we estimated that over66 million children in high-mortality countries who could
benefit from antibiotic therapy are not treated, and that
there is wide variability across countries in care-seeking
and antibiotic treatment patterns for children with pre-
sumed ALRI.
Cultural and political factors may influence care-seeking
behaviors. Some of the lowest proportions of parents seek-
ing any care for their child’s illness were in Central African
Republic, Burundi, and Sierra Leone. These were also the
countries with some of the highest percentages of parents
seeking public sector care. It is possible that the low level
of care-seeking in these countries is related to a relative
lack of private sector healthcare. Each of these countries
has experienced extensive political instability which may
have influenced the overall availability of care and the abil-
ity of parents to seek care. On the opposite side of the
spectrum, Bangladesh, Tanzania, Syria and Pakistan each
had high levels of access to care, but low percentages
accessing public sector care. Although the private sector is
well established, it is generally less regulated, and sales of
inappropriate drugs are a recurrent problem [24].
In the countries with available DHS and MICS data,
antibiotic treatment levels among children with presumed
ALRI were quite low. There was wide variation in antibiotic
Table 2 Percent of ALRI cases receiving antibiotics, according to Phase 5/6 DHS and MICS 3/4
DHS MICS
Country (year) Overall Urban Rural Country (year) Overall Urban Rural
Nepal (2011) 8% 9% 8% Yemen (2006) 13% 12% 13%
Swaziland (2006–7) 16% 18% 15% Cote D’Ivoire (2006) 19% 26% 16%
Ghana (2008) 24% 29% 21% Mozambique (2008) 22% 29% 19%
Namibia (2006–7) 36% 52% 31% Mauritania (2007) 24% 30% 19%
Zambia (2007) 47% 66% 39% Togo (2006) 26% 27% 25%
Kenya (2008–9) 50% 46% 50% Malawi (2006) 30% 38% 28%
Pakistan (2006–7) 51% 56% 49% Central African Republic (2010) 31% 47% 23%
Uganda (2011) 51% 59% 50% Somalia (2006) 32% 49% 24%
Liberia (2011) 54% 62% 51% Cameroon (2006) 38% 58% 27%
Egypt (2008) 58% 63% 54% Guinea (2006) 42% 55% 33%
Jordan (2007) 87% 87% 91% Djibouti (2006) 43% 43% 20%
Gambia (2005) 61% 60% 62%
Afghanistan (2010–11) 64% 70% 63%
Mongolia (2005) 71% 72% 71%
Syria (2006) 71% 75% 66%
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curring in rural areas.
To our knowledge, no other studies have attempted to
predict the burden of untreated pneumonia in high-
mortality countries for which no publically available data
exist. This prediction model provides meaningful estimates
of the number of untreated children for mathematical
models seeking to estimate how much disease could be
resolved if treatment guidelines were followed, and how
many prognoses can be improved. Although the DHS and
MICS provide the most extensive methodologically com-
parable collection of datasets for global estimation, there
are several limitations that may bias estimates of care-
seeking and proportion of cases treated with antibiotics.
The DHS data available spanned several years, so the
model findings are most applicable to the years between
2005 and 2010. Due to the nature of self-report in the
DHS, it is also likely that the DHS definition of ALRI is
neither sensitive nor specific for radiographically con-
firmed pneumonia, and thus we would hope to observe
fewer than 100% of cases treated with antibiotics [25].
Recent studies have posited that the antibiotic treatment
estimates derived from DHS and MICS data cannot beTable 3 Country-level general linear regression model
predicting proportion of ALRI cases who were treated
with antibiotics
Covariate Coefficient P-value 95% CI
Percent Urban −0.00388 0.067 −0.0080 – 0.0003
Under 5 mortality* 0.105 0.030 0.0102 – 0.1998
*Log transformed (natural log) under-five mortality per 1,000 live births per year.accurate because of this low sensitivity and specificity of
pneumonia recognition [26]. Furthermore, the DHS and
MICS rely on maternal recall of antibiotic treatment, the
challenges of which are well documented in the literature
[26]. However, in this prediction model, we applied esti-
mates of the proportion of children receiving antibiotics
derived from DHS/MICS to CHERG estimates of pneu-
monia incidence, which is a more specific characterization
of pneumonia burden than in the DHS. With large enough
sample sizes, we expect that bias in the DHS/MICS anti-
biotic treatment proportions would only be introduced
from differential treatment provision based on the severity
of illness of those ALRI cases included in the DHS. The
extent and direction of this bias is unclear, and further
study is necessary.
The prediction model estimated that 66 million cases of
ALRI go untreated every year. While the best model was
fit from the data which were publically available, the pre-
dicted estimates from the linear model for countries with
available DHS or MICS data were often much closer to the
mean than the observed data. Because of this, the model is
limited in its capacity to estimate the burden of untreated
ALRI for individual countries. However, the model reflects
improved estimates of the total burden for these high
mortality countries by encompassing predictive indica-
tors for countries without data. With the sampling vari-
ability of DHS estimations, particularly when combined
with CHERG predictions, the estimates for each country
have a wide predictive range; therefore the absolute num-
ber of untreated cases for each country should be inter-
preted with caution.
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ALRI is a major contributor to child mortality in deve-
loping countries. Our analysis shows that there are large
numbers of children with ALRI who are not treated with
antibiotics, representing an enormous missed opportu-
nity to prevent mortality. While the WHO estimated
that globally 30% of children are untreated for pneumo-
nia, our data suggest that, in high mortality countries, over
50% of children may be untreated. It is likely that this high
proportion of untreated children is adding to the overall
mortality rate of these countries. Additionally, there is
likely unnecessary usage of antibiotics which, given the
multibillion dollar global market in antibiotics, represents
wasted funds that could be redirected to support evidence-
based health care practices. Integrated initiatives such as
community case management of pneumonia have re-
cently been demonstrated to be effective for appropriately
providing treatment to children with pneumonia [27-30].
These community-based interventions promote both care-
seeking and appropriate antibiotic treatment, and ultimately
reduce mortality due to untreated ALRI.
Additional file
Additional file 1: CHERG ALRI estimates and predictive model output.
Country-level data table for the CHERG estimates of ALRI and the output of
the predictive model demonstrating the burden of untreated ALRI.
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